主动监测前列腺癌患者中癌症特异性焦虑与疾病侵袭性的关联
该回顾性分析纳入REDEEM研究的302例主动监测前列腺癌患者,使用MAX-PC问卷在基线及多个时间点评估焦虑。结果发现焦虑评分从基线的中度水平总体下降,但在收到18个月PSA结果后略有升高;阳性穿刺核心百分比与基线焦虑相关(P=0.02),校正后仍显著(P=0.003);基线焦虑与进展至停止主动监测的时间无显著关联。
要点
- 主动监测患者焦虑水平随时间总体下降,但PSA结果公布后可短暂升高。
- 阳性穿刺核心百分比越高,基线焦虑水平越高(P=0.02,校正后P=0.003)。
- 基线焦虑水平未显著影响进展至停止主动监测的时间。
核心结论
- 主动监测前列腺癌患者焦虑水平随时间下降,但PSA结果可致短暂升高。
- 疾病侵袭性(阳性核心百分比)与基线焦虑相关,但焦虑不影响临床或治疗进展。
研究设计与样本
- 回顾性分析REDEEM研究全部302例主动监测前列腺癌患者。
- 于基线及随机化后3、6、12、18、36个月使用MAX-PC问卷评估焦虑。
- 在18和36个月进行前列腺穿刺活检。
主要发现
- MAX-PC评分从基线的中度水平总体下降,18个月收到PSA结果后略有升高,随后继续下降。
- 阳性核心百分比与基线焦虑相关(P=0.02),校正年龄、种族、穿刺针数、BMI、前列腺体积和最大核心长度后仍显著(P=0.003)。
- 单变量和多变量分析中,基线焦虑与进展至停止主动监测的时间无显著关联。
临床怎么用
- 对主动监测患者应关注PSA结果告知时的焦虑波动。
- 阳性核心百分比高的患者基线焦虑可能更高,可考虑针对性心理支持。
- 基线焦虑水平不预示主动监测的终止,不应作为决策依据。
局限性
- 回顾性分析,仅纳入REDEEM研究人群。
- 焦虑测量使用MAX-PC问卷,未报告其他心理社会因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Active surveillance (AS) provides appropriate prostate cancer (PCa)-specific survival while minimizing morbidity, but underlying worry of PCa can generate anxiety. The aim of the study is to evaluate anxiety levels in men on AS and how anxiety relates to disease characteristics and treatment decision-making. METHODS: A retrospective analysis was conducted using all 302 subjects from the Reduction by Dutasteride of clinical progression Events in Expectant Management (REDEEM) study. Prostate biopsies were obtained at 18 and 36 months. Anxiety was measured at baseline and 3, 6, 12, 18, and 36 months post-randomization using the MAX-PC (Memorial general anxiety scale for PCa) questionnaire. Univariable and multivariable analysis of the association of disease aggressiveness (PSA levels, percentage of positive cores, and maximum core involvement) and anxiety levels were performed. Cox regression was used to analyze time to progression to discontinuation of active surveillance as a function of baseline anxiety. RESULTS: Overall, MAX-PC scores decreased from moderate at baseline with slight increases after receiving PSA results at 18 months, followed by more decline. Percentage of positive cores was associated with baseline anxiety (P = 0.02). The association remained when controlling for age, race, number of cores sampled, body mass index, prostate volume, and maximum core length (P = 0.003). In univariable and multivariable analysis, baseline anxiety was not significantly associated with time to progression to discontinuation of active surveillance. CONCLUSIONS: In evaluating the natural history of anxiety levels among patients with prostate cancer undergoing active surveillance, there was a decline of anxiety levels over time, with increases after receiving PSA results. Moreover, we found that disease aggressiveness measured by percentage of positive biopsy cores was associated with baseline levels of anxiety. However, anxiety had no impact on clinical or therapeutic progression.
引用
- Naha U, Freedland SJ, Abern MR, et al. The association of cancer-specific anxiety with disease aggressiveness in men on active surveillance of prostate cancer. Prostate Cancer Prostatic Dis. 2020. PMID: 32901094. doi:10.1038/s41391-020-00279-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。